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The hydrophilic bile acid ursodeoxycholic acid (UDCA),
which in vivo is converted to its taurine conjugate taur-
oursodeoxycholic acid (TUDC), is a mainstay in the
treatment of cholestatic liver disease. TUDC prevents
bile acid-induced cholestasis and induces choleresis. Its
beneficial effects involve an increased hepatobiliary secre-
tion as well as cytoprotective and antiapoptotic effects.
The choleretic effect of TUDC largely depends on a rapid
targeting and insertion of intracellularly stored transport
ATPases into the canalicular membrane, such as the bile
salt export pump (Bsep) and multidrug resistance
protein-2 (Mrp2) [1]. It was recently shown that
the TUDC-induced signaling involves phosphorylation of
the epidermal growth factor receptor (EGFR) at tyrosine
845 and 1173, but not Tyr1045. Tyr845, a known Src
kinase target, triggers an activating autophosphorylation
at Tyr1173 of the EGFR [2]. Furthermore, c-Src, focal
adhesion kinase (FAK), phosphatidylinositol 3-kinase
(PI3K) and Ras/Raf are activated within minutes by
TUDC, which triggers downstream dual activation of
extracellular signal-regulated kinases (Erks) and p38
mitogen-activated protein kinase (p38MAPK) [1-4].
Recent data indicate that integrins are a long-searched
sensor for TUDC in the liver, because TUDC interacts
with a5ß1 integrins in the liver resulting in a conforma-
tional change with activation of ß1 integrin and the initia-
tion of downstream integrin signaling. In contrast to the
previously reported ß1 integrin activation in response to
hypoosmolarity or insulin, TUDC-induced integrin acti-
vation occurs inside the hepatocyte and requires TUDC
uptake via the basolateral Na+/taurocholate cotransport-
ing polypeptide (Ntcp) [2]. However, other mechanisms
of TUDC action may contribute to its choleretic effect
under pathological cholestatic conditions.
Hepatocyte apoptosis can be triggered by the retention
of hydrophobic bile acids in hepatocytes by activation of
ligand-independent death receptor pathways in vivo and
in vitro. Toxic bile acids such as taurolithocholyl-3 sulfate
(TLCS) and glycochenodeoxycholate (GCDC) have
previously been shown to induce apoptosis in a CD95-
dependent apoptosis, involving activation of the acidic
sphingomyelinase, increased ceramide formation and acti-
vation of the protein kinase Cζ (PKCζ) followed by an oxi-
dative stress response via serine phosphorylation of
p47phox and NADPH oxidase activation. Putative inhibi-
tion of phosphatase activities by reactive oxygen species
(ROS) triggers an activation of the Src family kinase Yes
and activation of the c-Jun-N-terminal kinase-1/-2 (JNK).
The activated Yes kinase associates with the EGFR result-
ing in a Yes-mediated EGFR transactivation. Activated
EGFR then associates in a JNK-dependent way with CD95
and catalyzes CD95 tyrosine phosphorylation, which
triggers CD95 membrane trafficking, death-inducing
signaling complex (DISC) formation, i.e. association of
Fas-associated death domain (FADD) and caspase 8 to the
death receptor, followed by caspase 8-dependent mito-
chondrial amplification of pro-apoptotic signaling, which
finally leads to apoptotic cell death [5].
Bile salt-induced apoptosis can be antagonized by
TUDC. This cytoprotective effect of TUDC results from
an inhibition of JNK activation and CD95 trafficking to
the cell surface and activation of caspases 8 and 9 [6].
However, the molecular basis of TUDC-sensing with
regard to anti-apoptosis is not yet settled, but may involve
a TUDC-mediated inhibition of bile salt-induced phos-
phorylation of the MAP kinase kinase 4/7 (MKK4/7)
upstream of JNK activation Furthermore, similar to
cAMP, TUDC induced a protein kinase A (PKA)-sensitive
serine/threonine phosphorylation of the CD95 in presence
of GCDC, which was identified as an internalization signal
for CD95. Inhibition of hepatocyte apoptosis by cAMP
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involves both PKA-dependent serine/threonine phosphor-
ylation of the CD95 and inhibition of EGFR activation,
which results in an inhibition of CD95 tyrosine phosphor-
ylation, CD95 membrane targeting, and DISC formation.
mRNA analyses show that the dual specificity MAP kinase
phosphatase MKP-1, a transcriptionally regulated immedi-
ate early gene-encoded enzyme, is upregulated in response
to TUDC after stimulation with GCDC for up to 60 min,
which was already shown for cAMP [7]. Preliminary data
suggest that TUDC-induced integrin activation is involved
in mediating its anti-apoptotic effect.
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